The scientific performance of a journal is usually evaluated by the journal impact factor published every two years by Clarivate Analytics. Other bibliometric parameters described to understand a journal\'s impact are the Eigenfactor, article influence score, SCImago journal rank, and source-normalized impact per paper.\[[@ref1]\] However, there are many aspects of literature published by a journal which are not captured by these metrics. A more detailed analysis of such literature published in the journal over a period of time helps to identify types of manuscripts published, subspecialty wise distribution of publications and their time trends, and the impact of these publications on global literature. The specific methodology used to measure the quantity and quality of the literature and its impact is termed "scientometrics." Though most publishers and journal editors indulge in scientometric analysis, these are seldom published for consumption of the readers.

The Indian journal of ophthalmology (IJO) is a peer-reviewed open access monthly publication by the All India Ophthalmic Society (AIOS). It publishes technical and clinical articles in the field of ophthalmology under the terms of Creative Commons Attribution-Non Commercial-Share Alike 4.0 licenses. The journal started publishing articles from the year 1953 and has published around 66 volumes and 6456 articles till date. The Journal\'s impact factor for 2018 as reported in the 2019 Journal Citation Reports^®^ (Clarivate Analytics, 2018) was 0.977. Its SCIRank (2018) available from the 2017 SCImago Journal Rank of the journal was 0.498 and it was ranked in the third position in the field of ophthalmology in the Asiatic region.

Scientometric analysis has been employed previously to analyze the impact of published literature in many different faculties of medicine.\[[@ref2][@ref3]\] Ophthalmic literature has also been subjected to scientometrics in the past including for specific journals\[[@ref4]\] as well as specific disease pathologies such as age-related macular degeneration, glaucoma, and diabetic retinopathy.\[[@ref5][@ref6][@ref7][@ref8]\] A previous paper showed a bibliometric analysis of Indian ophthalmic papers published from 2001 to 2006 in the peer-reviewed journals, and assessed the productivity, trends in journal choice, publication types, research funding, and collaborative research from Indian ophthalmology.\[[@ref9]\] However, no study has performed a scientometric analysis of papers published in the IJO till date. In this study, we apply the scientometric methodology to the literature published in the IJO during the period between 2005 and 2017.

Methods {#sec1-2}
=======

Since the study did not involve human subjects directly, it was exempt from review by the local institutional ethics committee. All papers published in the IJO were obtained from PubMed using the advanced search builder option. In the builder, the field "Journal" was selected and "Indian Journal of Ophthalmology" was chosen to retrieve the results. The retrieved results were filtered by the publication date ranging from 01/01/2005 to 31/12/2017. Through the "Send to" file option, a total of 2,633 bibliographic records were downloaded in XML format. The reference records for the 2,633 bibliographic records were also extracted in XML format using E-Utilities, a free tool available on PubMed. The XML files were then converted to excel using the tool PubMed2Xls. The data in the excel files was imported to Microsoft-Access for further data cleaning and analysis. Using these tools, we generated a database consisting of the title of publications, type of article (original articles, case reports, review articles, editorials, and letter to editor), authors list in the order that appears on PubMed, institutional affiliations of all authors including country-wise distribution, the date of publication and indexing including the year of publication, volume, and page numbers, the number of references in each article, and any particular substance (chemical) being described in the paper. For ranking the institution, country and state, the affiliation of the first authors was used. A missing affiliation was updated by referring to the original articles available on the IJO website ([www.ijo.in](www.ijo.in)). Citation data for each published article, including the number of citations and the articles that had cited the papers as well as the journals in which these articles were published, was extracted from Google Scholar as available on 4^th^ October 2018.

Once data was tabulated, we performed a subspecialty wise distribution of the published literature and analyzed year-wise trends. The miscellaneous category included articles under history, low vision aids, microbiology, pathology, refraction, statistics, and teaching. The papers were then classified into original articles, review articles, editorials, case reports, letter to editor, and other type of manuscripts. All manuscripts with a tag of clinical study, clinical trial, comparative study, brief communication, controlled clinical trial, journal article, and randomized controlled trial were categorized as original articles. The "others" category included all other types of manuscripts including addresses, biography, comments, evaluation of other studies, historical articles, erratum, research support, retraction of publication, technical report, and video-audio media. Year-wise trends in types of articles published were also tabulated. Similarly, subspecialty wise articles were matched against the types of articles to see changing trends over time. The mean page length of articles was compared across years and tabulated. Authorship distribution was analyzed across the 12 years including the number of unique authors, authorship pattern, degree of collaboration, top institutions (Indian and foreign separately) contributing most to IJO, the top 10 countries published in IJO, and Indian state-wise distribution. Any paper with more than one author was perceived as collaborative research, in sync with scientometric techniques. To find out the degree of collaboration, the K. Subramanyam formula was used (Degree of collaboration = No. of papers with multiple authors/(No. of papers with multiple authors + No. of papers with single author)).

All data was entered in Microsoft Access and proportions were analyzed using Microsoft Excel. All proportions were presented as percentages (*n*, %). Comparison of variables across the years was done using the Chi square or the Fischer\'s exact test using STATA I/c version 12.1 I/C (Fort Worth, Texas, USA) and any *P* value less than 0.05 was considered statistically significant.

Results {#sec1-3}
=======

A total of 2633 articles were published in the IJO during the 12-year study period. [Table 1](#T1){ref-type="table"} shows exact year-wise distribution of the number of articles published along with the growth rate and percentage contributed by each year to the overall number. The number of articles increased steadily \[[Fig. 1](#F1){ref-type="fig"}\] from 2005 with the highest growth rate seen in 2013 followed by 2017. Almost 100 more articles were published in these two years compared to the immediate previous year. The papers published in 2017 (*n* = 355) contributed almost 14% of the entire literature published over the study period.

###### 

Published literature in IJO during the period 2005-2017

  Year    No. of literature (C)   Percentage (C/N)   Growth rate
  ------- ----------------------- ------------------ -------------
  2005    74                      2.8%               
  2006    92                      3.5%               24.3%
  2007    164                     6.2%               78.3%
  2008    152                     5.8%               -7.3%
  2009    132                     5.0%               -13.2%
  2010    165                     6.3%               25.0%
  2011    192                     7.3%               16.4%
  2012    160                     6.1%               -16.7%
  2013    257                     9.8%               60.6%
  2014    334                     12.7%              30.0%
  2015    290                     11.0%              -13.2%
  2016    266                     10.1%              -8.3%
  2017    355                     13.5%              33.5%
  Total   2,633 (N)               100%               

![Time trends in the number of articles published in the IJO from 2005 to 2017](IJO-68-738-g001){#F1}

The page length varied between 1 and 5 pages in majority papers (*n* = 2214, 84%) while 15% had page length between 5 and 10 pages (*n* = 394), and only 25 articles (*n* = 0.9%) had page length of 11 pages or more and all of these were review articles. The availability of substances used in the IJO literature for the period 2005--2017 was available only for 823 articles with about 608 unique substances enlisted. Angiogenesis inhibitors were the commonest substance (*n* = 175 articles, 21%) followed by glucocorticoids (*n* = 85, 10%).

Subspecialty wise analysis {#sec2-1}
--------------------------

[Table 2](#T2){ref-type="table"} shows the subspecialty wise distribution of articles published in IJO across the study period. Articles related to vitreoretinal diseases contributed nearly one-fourth of all the articles published (*n* = 598, 23%) followed by articles related to corneal diseases (12%), cataract (11%), and orbit and oculoplasty (9%). The miscellaneous section contributed 17% of all articles published. Time trends show that retina-related articles contributed a maximum of 31% in 2005 and a minimum of 18% in 2014. There was a sudden dip in the number of retina articles between 2014 and 2016 but since then more than 20% of all articles are related to diseases of the retina (*P* = 0.03).

###### 

Subspecialty wise distribution of articles over the study period

  Subject                   2005         2006         2007         2008         2009         2010         2011         2012         2013         2014         2015         2016         2017         Total
  ------------------------- ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------ -------------
  Cataract and IOL          6 (8.1%)     10 (10.9%)   19 (11.6%)   11 (7.2%)    18 (13.6%)   24 (14.5%)   16 (8.3%)    17 (10.6%)   24 (9.3%)    43 (12.9%)   24 (8.3%)    21 (7.9%)    60 (16.9%)   293 (11.1%)
  Community ophthalmology   1 (1.4%)     1 (1.1%)     0 (0%)       1 (0.7%)     2 (1.5%)     5 (3%)       2 (1%)       9 (5.6%)     4 (1.6%)     6 (1.8%)     5 (1.7%)     9 (3.4%)     5 (1.4%)     50 (1.9%)
  Cornea                    11 (14.9%)   14 (15.2%)   34 (20.7%)   22 (14.5%)   12 (9.1%)    19 (11.5%)   27 (14.1%)   19 (11.9%)   39 (15.2%)   29 (8.7%)    13 (4.5%)    21 (7.9%)    53 (14.9%)   313 (11.9%)
  General Ophthalmology     0 (0%)       0 (0%)       1 (0.6%)     0 (0%)       0 (0%)       0 (0%)       0 (0%)       0 (0%)       0 (0%)       0 (0%)       0 (0%)       0 (0%)       5 (1.4%)     6 (0.2%)
  Glaucoma                  6 (8.1%)     6 (6.5%)     3 (1.8%)     6 (3.9%)     11 (8.3%)    10 (6.1%)    39 (20.3%)   5 (3.1%)     16 (6.2%)    31 (9.3%)    21 (7.2%)    23 (8.6%)    18 (5.1%)    195 (7.4%)
  Miscellaneous             9 (12.2%)    10 (10.9%)   14 (8.5%)    19 (12.5%)   18 (13.6%)   17 (10.3%)   13 (6.8%)    50 (31.3%)   39 (15.2%)   73 (21.9%)   87 (30%)     62 (23.3%)   34 (9.6%)    445 (16.9%)
  Neurophthalmology         3 (4.1%)     5 (5.4%)     6 (3.7%)     6 (3.9%)     9 (6.8%)     6 (3.6%)     13 (6.8%)    5 (3.1%)     12 (4.7%)    29 (8.7%)    7 (2.4%)     11 (4.1%)    19 (5.4%)    131 (5%)
  Oncology                  0 (0%)       1 (1.1%)     2 (1.2%)     0 (0%)       0 (0%)       1 (0.6%)     0 (0%)       1 (0.6%)     2 (0.8%)     9 (2.7%)     27 (9.3%)    12 (4.5%)    13 (3.7%)    68 (2.6%)
  Optics and Refraction     0 (0%)       0 (0%)       0 (0%)       0 (0%)       0 (0%)       0 (0%)       2 (1%)       2 (1.3%)     3 (1.2%)     4 (1.2%)     1 (0.3%)     0 (0%)       0 (0%)       12 (0.5%)
  Orbit and Oculoplasty     11 (14.9%)   11 (12%)     14 (8.5%)    28 (18.4%)   17 (12.9%)   10 (6.1%)    18 (9.4%)    9 (5.6%)     19 (7.4%)    29 (8.7%)    24 (8.3%)    32 (12%)     18 (5.1%)    240 (9.1%)
  Pediatric ophthalmology   1 (1.4%)     6 (6.5%)     4 (2.4%)     3 (2%)       6 (4.5%)     5 (3%)       5 (2.6%)     4 (2.5%)     2 (0.8%)     4 (1.2%)     2 (0.7%)     2 (0.8%)     18 (5.1%)    62 (2.4%)
  Refractive Surgery        0 (0%)       0 (0%)       1 (0.6%)     0 (0%)       0 (0%)       1 (0.6%)     0 (0%)       0 (0%)       0 (0%)       0 (0%)       1 (0.3%)     0 (0%)       0 (0%)       3 (0.1%)
  Retina                    23 (31.1%)   21 (22.8%)   50 (30.5%)   33 (21.7%)   25 (18.9%)   43 (26.1%)   52 (27.1%)   33 (20.6%)   69 (26.8%)   61 (18.3%)   56 (19.3%)   51 (19.2%)   81 (22.8%)   598 (22.7%)
  Squint                    0 (0%)       1 (1.1%)     6 (3.7%)     12 (7.9%)    8 (6.1%)     9 (5.5%)     4 (2.1%)     3 (1.9%)     7 (2.7%)     11 (3.3%)    12 (4.1%)    5 (1.9%)     11 (3.1%)    89 (3.4%)
  Trauma                    0 (0%)       1 (1.1%)     2 (1.2%)     2 (1.3%)     0 (0%)       2 (1.2%)     0 (0%)       0 (0%)       6 (2.3%)     3 (0.9%)     2 (0.7%)     5 (1.9%)     4 (1.1%)     27 (1%)
  Uvea                      3 (4.1%)     5 (5.4%)     8 (4.9%)     9 (5.9%)     6 (4.5%)     13 (7.9%)    1 (0.5%)     3 (1.9%)     15 (5.8%)    2 (0.6%)     8 (2.8%)     12 (4.5%)    16 (4.5%)    101 (3.8%)
  Total                     74 (100%)    92 (100%)    164 (100%)   152 (100%)   132 (100%)   165 (100%)   192 (100%)   160 (100%)   257 (100%)   334 (100%)   290 (100%)   266 (100%)   355 (100%)   2633 (100%)

Types of articles published {#sec2-2}
---------------------------

[Table 3](#T3){ref-type="table"} shows a distribution of types of articles published in IJO between 2005 and 2017. Case reports and original articles contributed approximately two-third of all articles published. Year-wise trends showed that case reports contributed a higher number of publications between 2005 and 2010 after which there was a significant reduction from 2011 to 2015 (*P* = 0.02). Since 2016, the numbers of case reports have gradually increased again. Similar trends were not found for original articles with only 2007 showing much smaller numbers compared to the rest of the years. Subspecialty wise analysis of article types showed that maximum number of original articles (21%) and case reports (29%) were contributed by articles related to vitreoretinal diseases \[[Table 4](#T4){ref-type="table"}\]. The maximum number of review articles were under the miscellaneous section (20%) followed by cornea-related articles (16%). Out of the total of 598 retina-related articles, 30% (*n* = 182) were original articles and 44% (*n* = 262) were case reports. Similar trends were seen in cornea-related articles where original articles (*n* = 117) and case reports (*n* = 117) contributed to 37% each of the literature. In cataract-related papers, again 37% were original articles (*n* = 111) and 25% (*n* = 75) were case reports. In Oculoplasty, only 19% (*n* = 47) were original articles, while majority (60%, *n* = 142) were case reports.

###### 

Type of article and distribution over the study period

  Publication type   2005         2006         2007         2008         2009         2010         2011         2012         2013         2014          2015         2016         2017         Total
  ------------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------- ------------ ------------ ------------ -------------
  Case report        28 (37.8%)   38 (41.3%)   78 (47.6%)   65 (42.8%)   51 (38.6%)   61 (37%)     61 (31.8%)   52 (32.5%)   77 (30%)     92 (27.5%)    82 (28.3%)   98 (36.8%)   28 (37.8%)   894 (34%)
  Editorial          4 (5.4%)     4 (4.3%)     8 (4.9%)     7 (4.6%)     6 (4.5%)     5 (3%)       8 (4.2%)     7 (4.4%)     16 (6.2%)    12 (3.6%)     16 (5.5%)    14 (5.3%)    4 (5.4%)     138 (5.2%)
  Letter to editor   10 (13.5%)   13 (14.1%)   22 (13.4%)   20 (13.2%)   18 (13.6%)   42 (25.5%)   40 (20.8%)   25 (15.6%)   55 (21.4%)   55 (16.5%)    75 (25.9%)   41 (15.4%)   10 (13.5%)   437 (16.6%)
  Original article   28 (37.8%)   25 (27.2%)   36 (22%)     46 (30.3%)   46 (34.8%)   48 (29.1%)   68 (35.4%)   48 (30%)     74 (28.8%)   144 (43.1%)   77 (26.6%)   92 (34.6%)   28 (37.8%)   862 (32.7%)
  Others             3 (4.1%)     6 (6.5%)     10 (6.1%)    5 (3.3%)     6 (4.5%)     4 (2.4%)     7 (3.6%)     3 (1.9%)     8 (3.1%)     11 (3.3%)     12 (4.1%)    6 (2.3%)     3 (4.1%)     100 (3.8%)
  Review article     1 (1.4%)     6 (6.5%)     10 (6.1%)    9 (5.9%)     5 (3.8%)     5 (3%)       8 (4.2%)     25 (15.6%)   27 (10.5%)   20 (6%)       28 (9.7%)    15 (5.6%)    1 (1.4%)     202 (7.7%)
  Total              74 (100%)    92 (100%)    164 (100%)   152 (100%)   132 (100%)   165 (100%)   192 (100%)   160 (100%)   257 (100%)   334 (100%)    290 (100%)   266 (100%)   74 (100%)    2633 (100%)

###### 

Subject-wise distribution of article type over the study period

  Subject                   Review Article   Original Article   Editorial    Letter to Editor   Case Report   Others       Total
  ------------------------- ---------------- ------------------ ------------ ------------------ ------------- ------------ -------------
  Cataract & IOL            20 (9.9%)        111 (12.9%)        4 (2.9%)     65 (14.9%)         75 (8.4%)     18 (18%)     293 (11.1%)
  Community ophthalmology   6 (3%)           32 (3.7%)          3 (2.2%)     5 (1.1%)           2 (0.2%)      2 (2%)       501 (1.9%)
  Cornea                    33 (16.3%)       117 (13.6%)        8 (5.8%)     26 (5.9%)          117 (13.1%)   12 (12%)     313 (11.9%)
  General Ophthalmology     0 (0%)           2 (0.2%)           2 (1.4%)     1 (0.2%)           1 (0.1%)      0 (0%)       6 (0.2%)
  Glaucoma                  12 (5.9%)        112 (13%)          6 (4.3%)     18 (4.1%)          33 (3.7%)     14 (14%)     195 (7.4%)
  Miscellaneous             40 (19.8%)       116 (13.5%)        86 (62.3%)   111 (25.4%)        69 (7.7%)     23 (23%)     445 (16.9%)
  Neurophthalmology         9 (4.5%)         37 (4.3%)          0 (0%)       22 (5%)            63 (7%)       0 (0%)       131 (5%)
  Oncology                  16 (7.9%)        13 (1.5%)          3 (2.2%)     5 (1.1%)           30 (3.4%)     1 (1%)       68 (2.6%)
  Optics and Refraction     1 (0.5%)         7 (0.8%)           0 (0%)       3 (0.7%)           1 (0.1%)      0 (0%)       12 (0.5%)
  Orbit and Oculoplasty     14 (6.9%)        47 (5.5%)          1 (0.7%)     30 (6.9%)          142 (15.9%)   6 (6%)       240 (9.1%)
  Pediatric ophthalmology   2 (1%)           30 (3.5%)          4 (2.9%)     17 (3.9%)          8 (0.9%)      1 (1%)       62 (2.4%)
  Refractive Surgery        0 (0%)           2 (0.2%)           0 (0%)       0 (0%)             0 (0%)        1 (1%)       3 (0.1%)
  Retina                    28 (13.9%)       182 (21.1%)        16 (11.6%)   97 (22.2%)         262 (29.3%)   13 (13%)     598 (22.7%)
  Squint                    2 (1%)           31 (3.6%)          1 (0.7%)     25 (5.7%)          25 (2.8%)     5 (5%)       89 (3.4%)
  Trauma                    0 (0%)           8 (0.9%)           1 (0.7%)     2 (0.5%)           15 (1.7%)     1 (1%)       27 (1%)
  Uvea                      19 (9.4%)        15 (1.7%)          3 (2.2%)     10 (2.3%)          51 (5.7%)     3 (3%)       101 (3.8%)
  Total                     202 (100%)       862 (100%)         138 (100%)   437 (100%)         894 (100%)    100 (100%)   2633 (100%)

Analysis of references used in published articles {#sec2-3}
-------------------------------------------------

A total of 34,956 references were cited in all papers published by the IJO during the study period. Papers under the vitreoretina domain used the most number of references \[[Table 5](#T5){ref-type="table"}\] with each paper citing about 12 references. Cornea and cataract related diseases used the second and third highest number of references. The journal "Ophthalmology" was cited most often (*n* = 3379, 10%) followed by the American Journal of Ophthalmology (*n* = 2488, 7%) and the IJO (*n* = 2268, 6.6%).

###### 

Subject-wise reference count distribution over years

  Subject                   2005          2006        2007          2008          2009          2010          2011           2012          2013          2014           2015           2016          2017           Total
  ------------------------- ------------- ----------- ------------- ------------- ------------- ------------- -------------- ------------- ------------- -------------- -------------- ------------- -------------- --------------
  Cataract and IOL          1 (0.2%)      3 (10.3%)   47 (6.8%)     137 (6.8%)    338 (19.5%)   269 (14.2%)   214 (7.2%)     212 (10.2%)   265 (8.2%)    630 (12.1%)    242 (5.6%)     292 (7.7%)    1328 (20.4%)   3978 (11.4%)
  Community ophthalmology   1 (0.2%)      0 (0%)      0 (0%)        20 (1%)       8 (0.5%)      86 (4.5%)     21 (0.7%)      150 (7.2%)    33 (1%)       114 (2.2%)     94 (2.2%)      194 (5.1%)    99 (1.5%)      820 (2.3%)
  Cornea                    130 (30.2%)   2 (6.9%)    67 (9.6%)     330 (16.3%)   278 (16%)     151 (8%)      267 (9%)       334 (16%)     660 (20.5%)   480 (9.2%)     255 (5.9%)     334 (8.8%)    1190 (18.3%)   4478 (12.8%)
  General Ophthalmology     0 (0%)        0 (0%)      1 (0.1%)      0 (0%)        0 (0%)        0 (0%)        0 (0%)         0 (0%)        0 (0%)        0 (0%)         0 (0%)         0 (0%)        35 (0.5%)      36 (0.1%)
  Glaucoma                  24 (5.6%)     6 (20.7%)   0 (0%)        108 (5.3%)    262 (15.1%)   143 (7.6%)    1288 (43.2%)   134 (6.4%)    243 (7.5%)    746 (14.3%)    517 (11.9%)    442 (11.7%)   393 (6%)       4306 (12.3%)
  Miscellaneous             49 (11.4%)    2 (6.9%)    50 (7.2%)     303 (15%)     153 (8.8%)    154 (8.1%)    147 (4.9%)     581 (27.9%)   408 (12.7%)   1061 (20.3%)   1065 (24.5%)   741 (19.6%)   492 (7.6%)     5206 (14.9%)
  Neurophthalmology         12 (2.8%)     2 (6.9%)    24 (3.5%)     78 (3.9%)     88 (5.1%)     47 (2.5%)     294 (9.9%)     33 (1.6%)     118 (3.7%)    519 (9.9%)     42 (1%)        111 (2.9%)    290 (4.5%)     1658 (4.7%)
  Oncology                  0 (0%)        0 (0%)      17 (2.4%)     0 (0%)        0 (0%)        8 (0.4%)      0 (0%)         24 (1.2%)     66 (2%)       101 (1.9%)     786 (18%)      218 (5.8%)    204 (3.1%)     1424 (4.1%)
  Optics and Refraction     0 (0%)        0 (0%)      0 (0%)        0 (0%)        0 (0%)        0 (0%)        7 (0.2%)       29 (1.4%)     22 (0.7%)     78 (1.5%)      1 (0%)         0 (0%)        0 (0%)         137 (0.4%)
  Orbit and Oculoplasty     24 (5.6%)     2 (6.9%)    33 (4.7%)     210 (10.4%)   177 (10.2%)   69 (3.6%)     154 (5.2%)     123 (5.9%)    136 (4.2%)    314 (6%)       267 (6.1%)     493 (13%)     225 (3.5%)     2227 (6.4%)
  Pediatric ophthalmology   1 (0.2%)      6 (20.7%)   1 (0.1%)      60 (3%)       53 (3.1%)     30 (1.6%)     46 (1.5%)      54 (2.6%)     10 (0.3%)     86 (1.6%)      9 (0.2%)       56 (1.5%)     343 (5.3%)     755 (2.2%)
  Refractive Surgery        0 (0%)        0 (0%)      0 (0%)        0 (0%)        0 (0%)        28 (1.5%)     0 (0%)         0 (0%)        0 (0%)        0 (0%)         1 (0%)         0 (0%)        0 (0%)         29 (0.1%)
  Retina                    180 (41.9%)   5 (17.2%)   412 (59.3%)   424 (21%)     209 (12%)     425 (22.5%)   511 (17.2%)    388 (18.6%)   810 (25.1%)   845 (16.2%)    799 (18.3%)    661 (17.5%)   1418 (21.8%)   7087 (20.3%)
  Squint                    0 (0%)        0 (0%)      15 (2.2%)     110 (5.4%)    123 (7.1%)    71 (3.8%)     20 (0.7%)      11 (0.5%)     63 (2%)       184 (3.5%)     112 (2.6%)     36 (1%)       175 (2.7%)     920 (2.6%)
  Trauma                    0 (0%)        0 (0%)      6 (0.9%)      22 (1.1%)     0 (0%)        16 (0.8%)     0 (0%)         0 (0%)        71 (2.2%)     24 (0.5%)      13 (0.3%)      24 (0.6%)     52 (0.8%)      228 (0.7%)
  Uvea                      8 (1.9%)      1 (3.4%)    22 (3.2%)     217 (10.7%)   46 (2.7%)     394 (20.8%)   10 (0.3%)      8 (0.4%)      318 (9.9%)    45 (0.9%)      152 (3.5%)     183 (4.8%)    263 (4%)       1667 (4.8%)
  Total                     430           29          695           2019          1735          1891          2979           2081          3223          5227           4355           3785          6507           34956

Author productivity and Institutional analysis {#sec2-4}
----------------------------------------------

Author productivity analysis showed that there were 5490 unique authors over the study period. The highest number of unique authors was seen in the year 2014 (*n* = 790). [Fig. 2](#F2){ref-type="fig"} shows the unique authors and cumulative authors over the study period. The commonest number of coauthors per paper was four (*n* = 608, 23%) followed by three (*n* = 532, 20%) and two (*n* = 434, 17%). The degree of collaboration was 0.86 across the study period. The top 10 first authors published a total of 215 papers over the period and all the top 10 authors were from India. Authors from a total of 64 countries published 2,271 articles in IJO. Majority of papers were published from India (*n* = 1,666, 63%) followed by Turkey (*n* = 125, 4.7%), USA (*n* = 86, 3.3%), UK (*n* = 45, 1.7%), and China (*n* = 41, 1.6%). In India, maximum papers originated in institutions from the state of Tamil Nadu (*n* = 378, 23%), followed by Maharashtra (*n* = 262, 16%) and New Delhi (*n* = 243, 15%). The Dr. Rajendra Prasad Centre for Ophthalmic Sciences, AIIMS published the maximum papers in the IJO (*n* = 147, 9%) followed by LV Prasad eye institute (*n* = 138, 8%), Sankara Nethralaya (*n* = 82, 5%), and Aravind eye hospital, Madurai (*n* = 74, 4.5%).

![Distribution of unique authors per year and cumulative authors over the study period](IJO-68-738-g002){#F2}

Citation analysis {#sec2-5}
-----------------

A total of 2,051 (77.9%) articles were cited by 24,952 articles during the 12-year study period while the remaining 582 (22.1%) were not cited at all. Most papers were cited between 1 and 10 times (*n* = 1382, 67%) followed by 11--20 times (*n* = 342, 17%), 21--30 times (*n* = 145, 7%), 31--40 times (*n* = 65, 3%), 40--100 times (*n* = 101, 5%), and more than 100 times (*n* = 16, 1%). [Fig. 3](#F3){ref-type="fig"} shows the citation pattern over time. Subspecialty wise citation analysis showed that articles related to retinal diseases were cited most often and these contribute almost 20% of all citations from the IJO followed by cornea-related articles (17%) \[[Table 6](#T6){ref-type="table"}\]. Original articles were cited much more frequently and constituted 50% of all citations (*n* = 13,008), followed by case reports (*n* = 5135, 20%) and review articles (*n* = 4278, 17%). Similarly, original articles had a much higher likelihood of getting cited (15.1 times per article) compared to case reports (5.7 times per article) (*P* \< 0.001), while review articles had the highest likelihood of getting cited (21 times per article). The top three highly cited articles were "Understanding and using sensitivity, specificity and predictive values" by Parikh, R., Mathai, A., Parikh, S., Sekhar, G. C., and Thomas, R., 2008 (418 citations), "Global variation and pattern changes in epidemiology of uveitis" by Rathinam, S. R. and Namperumalsamy, P. 2007 (244 citations), and "Review of epidemiological features, microbiological diagnosis and treatment outcome of microbial keratitis: experience of over a decade" by Gopinathan, U., Sharma, S., Garg, P., and Rao, G. N., 2009 (236 citations)."
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Subject-wise citation count distribution over years

  Subject                   2005          2006          2007          2008          2009          2010          2011          2012          2013          2014          2015          2016          2017         Total
  ------------------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------ --------------
  Cataract and IOL          174 (10.2%)   90 (6.4%)     155 (5.1%)    131 (4.6%)    471 (17.4%)   253 (10.7%)   159 (6.1%)    144 (7%)      198 (10.4%)   269 (12.7%)   60 (5.1%)     68 (10.6%)    58 (14.9%)   2230 (8.9%)
  Community ophthalmology   4 (0.2%)      26 (1.9%)     0 (0%)        114 (4%)      20 (0.7%)     128 (5.4%)    19 (0.7%)     329 (16%)     44 (2.3%)     65 (3.1%)     30 (2.5%)     79 (12.3%)    12 (3.1%)    870 (3.5%)
  Cornea                    492 (28.8%)   305 (21.8%)   826 (27.1%)   376 (13.2%)   593 (21.9%)   216 (9.2%)    324 (12.5%)   216 (10%)     661 (34.6%)   175 (8.3%)    79 (6.7%)     61 (9.5%)     68 (17.4%)   4392 (17.6%)
  General ophthalmology     0 (0%)        0 (0%)        1 (0%)        0 (0%)        0 (0%)        0 (0%)        0 (0%)        0 (0%)        0 (0%)        0 (0%)        0 (0%)        0 (0%)        3 (0.8%)     4 (0%)
  Glaucoma                  276 (16.2%)   132 (9.4%)    100 (3.3%)    135 (4.8%)    360 (13.3%)   163 (6.9%)    870 (33.6%)   89 (4.3%)     112 (5.9%)    210 (9.9%)    85 (7.2%)     50 (7.8%)     14 (3.6%)    2596 (10.4%)
  Miscellaneous             140 (8.2%)    77 (5.5%)     171 (5.6%)    773 (27.2%)   267 (9.8%)    318 (13.5%)   126 (4.9%)    586 (28%)     91 (4.8%)     380 (18%)     234 (19.8%)   105 (16.4%)   49 (12.6%)   3317 (13.3%)
  Neuro-Ophthalmology       39 (2.3%)     77 (5.5%)     116 (3.8%)    64 (2.3%)     100 (3.7%)    82 (3.5%)     322 (12.4%)   103 (5%)      91 (4.8%)     207 (9.8%)    21 (1.8%)     16 (2.5%)     10 (2.6%)    1248 (5%)
  Oncology                  0 (0%)        9 (0.6%)      47 (1.5%)     0 (0%)        0 (0%)        3 (0.1%)      0 (0%)        2 (0.1%)      36 (1.9%)     43 (2%)       233 (19.7%)   35 (5.5%)     23 (5.9%)    431 (1.7%)
  Optics and Refraction     0 (0%)        0 (0%)        0 (0%)        0 (0%)        0 (0%)        0 (0%)        14 (0.5%)     76 (3.7%)     14 (0.7%)     40 (1.9%)     0 (0%)        0 (0%)        0 (0%)       144 (0.6%)
  Orbit and Oculoplasty     121 (7.1%)    184 (13.1%)   182 (6%)      321 (11.3%)   231 (8.5%)    91 (3.9%)     170 (6.6%)    116 (5.6%)    76 (4%)       105 (5%)      73 (6.2%)     66 (10.3%)    15 (3.8%)    1751 (7%)
  Pediatric ophthalmology   26 (1.5%)     69 (4.9%)     76 (2.5%)     49 (1.7%)     89 (3.3%)     33 (1.4%)     40 (1.5%)     27 (1.3%)     6 (0.3%)      72 (3.4%)     1 (0.1%)      9 (1.4%)      27 (6.9%)    524 (2.1%)
  Refractive Surgery        0 (0%)        0 (0%)        9 (0.3%)      0 (0%)        0 (0%)        22 (0.9%)     0 (0%)        0 (0%)        0 (0%)        0 (0%)        0 (0%)        0 (0%)        0 (0%)       31 (0.1%)
  Retina                    404 (23.7%)   356 (25.4%)   965 (31.7%)   394 (13.9%)   355 (13.1%)   678 (28.7%)   529 (20.4%)   331 (16%)     377 (19.7%)   452 (21.4%)   290 (24.5%)   125 (19.5%)   80 (20.5%)   5336 (21.4%)
  Squint                    0 (0%)        5 (0.4%)      71 (2.3%)     238 (8.4%)    90 (3.3%)     39 (1.7%)     11 (0.4%)     12 (0.6%)     24 (1.3%)     72 (3.4%)     21 (1.8%)     1 (0.2%)      9 (2.3%)     593 (2.4%)
  Trauma                    0 (0%)        0 (0%)        15 (0.5%)     86 (3%)       0 (0%)        9 (0.4%)      0 (0%)        0 (0%)        72 (3.8%)     14 (0.7%)     10 (0.8%)     2 (0.3%)      7 (1.8%)     215 (0.9%)
  Uvea                      32 (1.9%)     70 (5%)       313 (10.3%)   158 (5.6%)    135 (5%)      324 (13.7%)   7 (0.3%)      24 (1.2%)     109 (5.7%)    12 (0.6%)     46 (3.9%)     25 (3.9%)     15 (3.8%)    1270 (5.1%)
  Total                     1708 (100%)   1400 (100%)   3047 (100%)   2839 (100%)   2711 (100%)   2359 (100%)   2591 (100%)   2055 (100%)   1911 (100%)   2116 (100%)   1183 (100%)   642 (100%)    390 (100%)   24952 (100%)

Discussion {#sec1-4}
==========

In this scientometric analysis of papers published in IJO from 2005 to 2017, we found a healthy trend of progressive increase in the number of papers published year after year. Articles related to vitreoretinal diseases contributed maximum articles almost every year and amounted to one out of every 5 papers published. Original articles and case reports were the main types of articles published with a slight reduction in the number of case reports over time. Not surprisingly, articles related to vitreoretinal diseases contributed the maximum number of original articles and case reports. The journal "Ophthalmology" was most commonly cited by the papers published in the IJO and angiogenesis inhibitors were the commonest chemical substance group mentioned in articles. We found more than 5000 unique authors from 64 countries contributing to articles over the study period, giving the journal some resemblance with its more illustrious international counterparts, though more than 60% authors were Indian. Less than 80% papers were cited over time with most papers being cited between 1 and 10 times and about 6% papers cited more than 40 times over 12 years. Vitreoretina-related articles were cited most and original articles had more than three times higher chance of getting cited compared to case reports.

The trend of increasing number of articles being published is a healthy one and shows a growing desire of Indian ophthalmologists to do more clinical research and publish papers. This is also evidenced by the development of the journal from a quarterly to bimonthly to a monthly journal over the study period. In a previous study spanning the last decade, Kumaragurupari showed that there was a growing trend of papers being published from India; however, 50% papers came from 9 major institutions.\[[@ref9]\] We found similar trends with four institutes contributing more than 25% of the published literature. In addition, a previous study showed that majority of papers presented at an all India conference are not published over the subsequent 5 years.\[[@ref10]\] Keeping these trends in mind, it may be prudent to encourage more clinical research and publications from other promising institutions across the country which experience high patient loads and hence are privy to abundant patient data.

It is not surprising that articles related to vitreoretinal diseases contributed a large majority of total articles published. A previous editorial in a retina special issue of the IJO by one of the editors also hinted at similar numbers and attributed this to the overall mood and direction of ophthalmic literature.\[[@ref11]\] This has also led to many national and international organizations and societies launching retina subspecialty journals over the past few years. These trends also show that the rate of innovations in the field of retinal diseases has outpaced most other subspecialties, especially imaging-related studies. Bibliometric trends in global ophthalmology from 1997 to 2009 also showed similar trends with a jump in the impact and ranking of the subspecialty journal "Retina."\[[@ref12]\]

Authorship-related scientometric analysis showed that 63% papers were published by Indian authors giving the journal content a predominantly Indian outlook, though authors from more than 60 countries contributed making it a truly international journal. However, given that most highly cited international papers originate out of America\[[@ref13][@ref14]\] and a relatively small proportion of papers in the IJO were authored by American authors, it may be wise to persuade more international authors to publish in the IJO. Since IJO is one of the few journals which are open access and do not charge a manuscript processing fee, it is an attractive option for most authors, especially if manuscript turnaround times are competitive and decisions arrive soon.

Citations are the start of a paper\'s journey once it is published and is a parameter that really determines the paper\'s quality and influence on the literature to follow. Citations are also utilized to calculate the impact factor of journals which in turn is used to rank journals, thus making this one of the most important parameters to study in detail. Analysis of citations over the study period showed that original articles were cited much more frequently compared to case reports published in the IJO. Though retina-related articles contributed greater number of citations, this was offset by the highest number of papers published under the vitreoretina domain. We also found that more than 20% of the papers, mostly case reports, were never cited over a 12-year period. Given the fact that original articles are cited more frequently, the IJO may do well to increase the proportion of original articles and reduce case reports, a trend which has already been observed.

A similar scientometric analysis was performed to evaluate the papers published in the Australian and New Zealand Journal of Ophthalmology (ANZJO) to its successor, Clinical and Experimental Ophthalmology.\[[@ref4]\] Disease specific scientometric analysis has also been performed for age-related macular degeneration and glaucoma.\[[@ref5][@ref6][@ref7]\] To the best of our knowledge, this is the first paper describing scientometric data from the IJO and will help readers and the editorial board get a better perspective of the direction in which the journal is headed in the future. The limitation of the study is that only the data available on PubMed was considered for the study for ease of export and availability of streamlined data points. However, the actual data of the journal which is not indexed in PubMed was not used for the analysis. For the ranking analysis of authors and institutions, only information from the first author was considered. Lastly, citation data after 4^th^ October 2018 was not considered in the study.

Conclusion {#sec1-5}
==========

In conclusion, an exhaustive scientometric analysis from the IJO showed a steady increase in the number of publications from year to year. Papers from the vitreoretinal domain were the commonest and were cited most often. Original articles and case reports contributed equally to the published content though the former were cited much more frequently than the latter. This information will help the journal to reevaluate and rejuvenate its activities. This will also be helpful to librarians to serve the ophthalmic community in a better way. Lastly, the readership will understand the scope of ophthalmic literature published by the journal over the study period which will motivate them to endeavor to perform new research and build up the journal quality.
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